Bajaj Healthcare Limited (BAJAJHCARE) — Board Meeting
The board approved the audited FY2025-26 standalone results showing a loss of ₹1941.28 lakhs, recommended a ₹1.50 per share (30% of face value) final dividend subject to shareholder approval, and reappointed auditors for FY2026-27. Total current liabilities rose to ₹31,956.24 lakhs from ₹27,226.63 lakhs, while cash and cash equivalents jumped to ₹3,723.54 lakhs from ₹260.38 lakhs. The unmodified auditor's report confirmed financial statement accuracy.
About Bajaj Healthcare Limited (BAJAJHCARE)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when BAJAJHCARE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track BAJAJHCARE — Free💡 Ask AI about this filing
📊 More BAJAJHCARE filings
- 🟡 deviation variation — 20 July 2026 Bajaj Healthcare Limited confirmed on July 20, 2026 that there is no deviation or variation in the u...
- 🟡 Board Meeting — 20 July 2026 Bajaj Healthcare Limited received a Monitoring Agency Report from CARE Ratings confirming proper uti...
- 🔴 Financial Results — 20 July 2026 Bajaj Healthcare reported a 69.9% YoY revenue jump to **₹16,644.31 lakhs** for Q1 FY26, driven by st...
- 🔴 Financial Results — 20 July 2026 Bajaj Healthcare reported Q1 FY27 revenue of **₹165.6 crores**, up 11.3% YoY and 8.2% QoQ, with PAT ...
- Announcement — 20 July 2026 Bajaj Healthcare announced on July 20, 2026 that its Nomination and Remuneration Committee approved ...
🔥 Also filed on 9 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when BAJAJHCARE files new disclosures
Track BAJAJHCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track BAJAJHCARE — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research